POU5F1 and renal cell carcinoma: While notch1/2 was suppressed by its pharmacological inhibitor MRK-003 or its endogenous inhibitor Numb, the expression of stemness markers (CTR2, BCL-2, OCT-4, KLF4 and MDR1) and stemness functional properties (self-renewal, high invasion and migration, resistance to cisplatin and sorafenib and strong tumorigenicity) were inhibited in RCC CSCs.